Almac, a CRO, partners with with FACIT.org for electronic distribution of the FACITs Patient-Reported-Outcomes(PRO) and Quality of Life (QOL) assessments.
Brief patient-completed questionnaire that evaluates patients' experiences with a specific named physician and that physician's practice.
In the Age of Metrics, vocation after vocation is discovering numbers. Doctors are going quant with evidence-based medicine, which promises to improve care by quantifying different treatments’ probabilities of success. (NYT, Nov. 21. 2009)
Assessment of Quality of Life (AQoL) utility instruments and their scoring algorithms are now available free of charge. The website also provides a user guide, answers to common questions, links to research papers and other websites and discussion of validation and other issues related to economic evaluation.
The National Quality Forum recently endorsed the proportion of days covered (PDC)
Patients can expect significant savings and better outcomes from their prescription medications when health care professionals use comparative effectiveness research, according to researchers at the University of Illinois at Chicago.
The Consumer Expenditure Survey (CE) program consists of two surveys, the Quarterly Interview Survey and the Diary Survey, that provide information on the buying habits of American consumers, including data on their expenditures, income, and consumer unit (families and single consumers) characteristics. The survey data are collected for the Bureau of Labor Statistics by the U.S. Census Bureau.
Used to assess the level of patient’s satisfaction or dissatisfaction with the "Convenience" of medication patients are taking.
Information on the threshold values used in CHOICE analyses for the relative CE of an intervention in current international dollars of 2000 for 14 countries. Following the recommendations of the Commission on Macroeconomics and Health, CHOICE uses gross domestic product (GDP) as a readily available indicator to derive the following three categories of cost-effectiveness: Highly cost-effective (less than GDP per capita); Cost-effective (between one and three times GDP per capita); and Not cost-effective (more than three times GDP per capita)
Kent Bottles discusses David Eddy's history and recent speech in this posting. (Source: ICSI Health Care Blog, Nov. 30, 2009)
"The proposal to include $1.1 billion for comparative-effectiveness research (CER) in the federal stimulus package encountered a vigorous and well-coordinated backlash. The campaign to gut this funding ultimately failed, but the debate it engendered and the resonance of the opposition's arguments in both lay and policy circles reveal much about the issues that will surround such research and its application in the coming years."
DIRUM is a practical, open-access database of resource-use questionnaires for use by trial health economists.
"The American Reinvestment and Recovery Act gives comparative-effectiveness research (CER) a large boost in funding over the next 2 years. Despite a consensus that better information about the relative effectiveness of different medical interventions is needed to improve the quality and value of care, some view CER with skepticism."
The "Effectiveness" scale on the Treatment Satisfaction Questionnaire for Medication (TSQM) is used to assess the level of satisfaction or dissatisfaction with the (perceived) "Effectiveness" of medication.
EQ-5D is a standardized instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments, it provides a simple descriptive profile and a single index value for health status that can be used in the clinical and economic evaluation of health care as well as population health surveys. EQ-5D has been specially designed to complement other quality of life measures such as the SF-36, NHP, SIP or disease-specific measures.
AHRQ Project designed to strengthen the science base of quality measurement while expanding the scope and availability of validated, ready-to-use measures. Q-SPAN builds on past work in quality measurement by public and private organizations through eight cooperative agreements to develop and test additional clinical performance measures for specific conditions, patient populations, and health care settings.
These instruments provide vital measures of the effectiveness of treatment as well as the general well-being and physical and psychological state of the patient.
(Source: Outsourcing Pharma.com)
Blog posting about November 2010 lecture questioning the value of EBM, by one of the formidable experts in the field. (Source: ICSI Health Care Blog)
AHRQ/QSPAN assessing the quality of care delivered in managed health care plans, this project will examine care delivered to men ages 18-50 and women age 50 and over. Conditions considered: Twenty-seven conditions for new indicator development (e.g., anxiety, colorectal cancer, prostate cancer, menopause); 12 to be adapted from the HCFA study (e.g., alcoholism, breast mass, diabetes, low back pain).
The "Global Satisfaction" scale of the Treatment Satisfaction Questionnaire for Medication (TSQM) is used to assess the overall level of satisfaction or dissatisfaction with medication patients are taking.
The AHRQ QIs are measures of quality associated with processes of care that
occurred in an outpatient or an inpatient setting.
Source for questionnaires
Overview, access to instruments, etc. from CDC
HEDIS® is the gold standard in health care performance measurement, used by more than 90 percent of the nation's health plans and many leading employers and regulators. HEDIS is a set of standardized measures that specifies how organizations collect, audit and report performance information across the most pressing clinical areas, as well as important dimensions of customer satisfaction and patient experience.
NCQA licenses organizations and certifies selected employees or contractees of licensed organizations to conduct audits using NCQA's standardized audit methodology. Auditors use the first half of the audit, the overall IS review, to identify data areas to focus on during the second half of the review (HEDIS Compliance Standards). This allows for customization of each audit depending on the individual health plan's strengths and weaknesses. The audit adds a higher degree of integrity to HEDIS data, and enables MCOs to provide consumers and purchasers with consistent and comparable HEDIS reports.